Interacting appetite-regulating pathways in the hypothalamic regulation of body weight.

Various aspects of the complex spatio-temporal patterning of hypothalamic signaling that leads to the development of synchronized nocturnal feeding in the rat are critically examined. Undoubtedly, as depicted in Fig. 7, a distinct ARN in the hypothalamus is involved in the control of nocturnal appetite. At least four basic elements operate within this ARN. These are: 1) A discrete appetite-driving or orexigenic network of NPY, NE, GABA, GAL, EOP, and orexin transduces and releases appetite-stimulating signals. 2) Similarly, anorexigenic signal-producing pathways (e.g., CRH, GLP-1, alpha MSH, and CART) orchestrate neural events for dissipation of appetite and to terminate feeding, possibly by interrupting NPY efflux and action at a postsynaptic level within the hypothalamus. It is possible that some of these may represent the physiologically relevant "off" switches under the influence of GABA alone, or AgrP alone, or in combination with NPY released from the NPY-, GABA-, and AgrP-coproducing neurons. 3) Recent evidence shows that neural elements in the VMN-DMN complex tonically restrain the orexigenic signals during the intermeal interval; the restraint is greatly aided by leptin's action via diminution of orexigenic (NPY) and augmentation of anorexigenic (GLP-1, alpha MSH, and CART) signals. Since interruption of neurotransmission in the VMN resulted in hyperphagia and development of leptin resistance, it seems likely that the VMN is an effector site for the restraint exercised by leptin. The daily rhythms in leptin synthesis and release are temporally dissociable because the onset of daily rise in leptin gene expression in adipocytes precedes that in leptin secretion. Nevertheless, these rhythms are in phase with daily ingestive behavior because the peak in circulating leptin levels occurs during the middle of the feeding period. These observations, coupled with the fact that circulating levels of leptin are directly related to adiposity, pose a new challenge for elucidating the precise role of leptin in daily patterning of feeding in the rat. 4) A neural timing mechanism also operates upstream from the ARN in the daily management of energy homeostasis. Although the precise anatomical boundaries are not clearly defined, this device is likely to be composed of a group of neurons that integrate incoming internal and external information for the timely onset of the drive to eat. Evidently, this network operates independently in primates, but it is entrained to the circadian time keeper in the SCN of rodents. Apart from its role in the onset of drive to eat, the circadian patterns of gene expression of NPY, GAL, and POMC denote independent control of the timing device on the synthesis and availability for release of orexigenic signals. The VMN-DMN-PVN complex is apparently an integrated constituent of the timing mechanism in this context, because lesions in each of these sites result in loss of regulated feeding. The accumulated evidence points to the PVN and surrounding neural sites within this framework as the primary sites of release and action of various orexigenic and anorexigenic signals. A novel finding is the identification of the interconnected wiring of the DMN-mPVN axis that may mediate leptin restraint on NPY-induced feeding. The chemical phenotypes of leptin and NPY target neurons in this axis remain to be identified. These multiple orexigenic and anorexigenic pathways in the hypothalamic ARN appear to represent redundancy, a characteristic of regulated biological systems to provide a "fail-safe" neural mechanism to meet an organism's constant energy needs for growth and maintenance. Within this formulation, the coexisting orexigenic signals (NPY, NE, GAL, GABA, and AgrP) represent either another level of redundancy or it is possible that these signals operate within the ARN as reinforcing agents to varying degrees under different circumstances. (ABSTRACT TRUNCATED)

[1]  I. Robinson,et al.  Differential Expression and Regulation of Leptin Receptor Isoforms in the Rat Brain: Effects of Fasting and Oestrogen , 1998, Neuroendocrinology.

[2]  J. Kamegai,et al.  Growth hormone receptor gene is expressed in neuropeptide Y neurons in hypothalamic arcuate nucleus of rats. , 1996, Endocrinology.

[3]  M. Dallman,et al.  Elevated corticosterone is not required for the rapid induction of neuropeptide Y gene expression by an overnight fast. , 1997, Endocrinology.

[4]  T. Horvath,et al.  Leptin Receptor Immunoreactivity is Associated with the Golgi Apparatus of Hypothalamic Neurones and Glial Cells , 1998, Journal of neuroendocrinology.

[5]  S. Dryden,et al.  Neuropeptide Y, the hypothalamus, and diabetes: Insights into the central control of metabolism , 1995, Peptides.

[6]  N. Ling,et al.  Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Brobeck,et al.  Hypothalamic Control of Food Intake in Rats and Cats * , 1951, The Yale journal of biology and medicine.

[8]  R. Palmiter,et al.  Increased expression of mRNA for the long form of the leptin receptor in the hypothalamus is associated with leptin hypersensitivity and fasting. , 1998, Diabetes.

[9]  G. Bray,et al.  Comparison of ventromedial and paraventricular lesions in rats that become obese. , 1986, The American journal of physiology.

[10]  M. G. Dube,et al.  Disruption of neural signaling within the hypothalamic ventromedial nucleus upregulates galanin gene expression in association with hyperphagia: an in situ hybridization analysis. , 1999, Brain research. Molecular brain research.

[11]  M. Mortrud,et al.  Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Ghatei,et al.  Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. , 1993, Endocrinology.

[13]  J. B. Tatro Melanotropin receptors in the brain are differentially distributed and recognize both corticotropin and α-melanocyte stimulating hormone , 1990, Brain Research.

[14]  K. Staley,et al.  Ionic mechanisms of neuronal excitation by inhibitory GABAA receptors , 1995, Science.

[15]  C. Mobbs,et al.  Ventromedial hypothalamic lesions produced by gold thioglucose do not impair induction of NPY mRNA in the arcuate nucleus by fasting , 1996, Brain Research.

[16]  F E Bloom,et al.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Moar,et al.  Localization of leptin receptor (Ob-R) messenger ribonucleic acid in the rodent hindbrain. , 1998, Endocrinology.

[18]  M. G. Dube,et al.  Neuropeptide Y release in the paraventricular nucleus is decreased during transient hyperphagia induced by microinjection of colchicine into the ventromedial nucleus of rats , 1998, Neuroscience Letters.

[19]  I. Merchenthaler,et al.  Anatomy and physiology of central galanin-containing pathways , 1993, Progress in Neurobiology.

[20]  Roy J Martin,et al.  Evidence for a Central Mechanism of Obesity in the Zucker Rat: Role of Neuropeptide Y and Leptin 1 , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[21]  A. Joyner,et al.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.

[22]  A. Steffens Influence of reversible obesity on eating behavior, blood glucose, and insulin in the rat. , 1975, The American journal of physiology.

[23]  B. Hoebel,et al.  Overeating and Obesity from Damage to a Noradrenergic System in the Brain , 1973, Science.

[24]  M. Herkenham,et al.  Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: Neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat , 1995, The Journal of comparative neurology.

[25]  B. McEwen,et al.  Hypothalamic neuropeptide Y, its gene expression and receptor activity: relation to circulating corticosterone in adrenalectomized rats , 1994, Brain Research.

[26]  R. D. Myers,et al.  Antisense to NPY-Y1 demonstrates that Y1 receptors in the hypothalamus underlie NPY hypothermia and feeding in rats , 1996, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[27]  G. Koob,et al.  Corticotropin-releasing factor in the paraventricular nucleus modulates feeding induced by neuropeptide Y , 1993, Brain Research.

[28]  R. Palmiter,et al.  Role of the Y5 neuropeptide Y receptor in feeding and obesity , 1998, Nature Medicine.

[29]  A. Sclafani,et al.  Chapter 2 – THE ROLE OF THE MEDIAL HYPOTHALAMUS IN THE CONTROL OF FOOD INTAKE: AN UPDATE , 1986 .

[30]  J. Morley,et al.  Muscimol induced feeding: a model to study the hypothalamic regulation of appetite. , 1981, Life sciences.

[31]  M. G. Dube,et al.  Neuropeptide Y release is elevated from the microdissected paraventricular nucleus of food-deprived rats: an in vitro study. , 1992, Endocrinology.

[32]  A. Guidotti,et al.  Stimulation of food intake by muscimol and beta endorphin , 1977, Neuropharmacology.

[33]  J. Bue-Valleskey,et al.  The role of neuropeptide Y in the antiobesity action of the obese gene product , 1995, Nature.

[34]  S. Kalra,et al.  Neuropeptide Y : a novel peptidergic signal for the control of feeding behavior , 1990 .

[35]  M. Rosenfeld,et al.  Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain , 1993, Neuron.

[36]  S. Watson,et al.  Molecular cloning of a novel melanocortin receptor. , 1993, The Journal of biological chemistry.

[37]  L. Bellinger,et al.  The lateral hypothalamic area revisited: Ingestive behavior , 1996, Neuroscience & Biobehavioral Reviews.

[38]  H. Donias,et al.  The lateral hypothalamus: a primary site mediating excitatory amino acid-elicited eating , 1993, Brain Research.

[39]  M. Schwartz,et al.  Differential effect of fasting on hypothalamic expression of genes encoding neuropeptide Y, galanin, and glutamic acid decarboxylase , 1993, Brain Research Bulletin.

[40]  B. Griffond,et al.  The synthesis of melanin-concentrating hormone is stimulated by ventromedial hypothalamic lesions in the rat lateral hypothalamus: a time-course study , 1995, Neuropeptides.

[41]  W. Banks,et al.  Leptin enters the brain by a saturable system independent of insulin , 1996, Peptides.

[42]  L. Vignati,et al.  Serum leptin levels in women with anorexia nervosa. , 1996, The Journal of clinical endocrinology and metabolism.

[43]  C. Saper,et al.  Leptin activates distinct projections from the dorsomedial and ventromedial hypothalamic nuclei. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  B. Beck,et al.  Neuropeptide Y release in the paraventricular nucleus of Long-Evans rats treated with leptin. , 1998, Biochemical and Biophysical Research Communications - BBRC.

[45]  Noriko Satoh,et al.  The arcuate nucleus as a primary site of satiety effect of leptin in rats , 1997, Neuroscience Letters.

[46]  A. Rosier,et al.  Visualization of gamma-aminobutyric acid A receptors on proopiomelanocortin-producing neurons in the rat hypothalamus. , 1994, Endocrinology.

[47]  J. Crawley Biological actions of galanin , 1995, Regulatory Peptides.

[48]  K. Hosoda,et al.  Pathophysiological significance of the obese gene product, leptin, in ventromedial hypothalamus (VMH)-lesioned rats: evidence for loss of its satiety effect in VMH-lesioned rats. , 1997, Endocrinology.

[49]  B. Stanley,et al.  Lateral hypothalamic injections of glutamate, kainic acid,d,l-α-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-d-aspartic acid rapidly elicit intense transient eating in rats , 1993, Brain Research.

[50]  P. Lambert,et al.  A role for GLP-1(7-36)NH2 in the central control of feeding behaviour , 1993 .

[51]  L. Siracusa The agouti gene: turned on to yellow. , 1994, Trends in genetics : TIG.

[52]  L. Swanson,et al.  The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat , 1983, The Journal of comparative neurology.

[53]  T. Hökfelt,et al.  The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[54]  B. Beck,et al.  Neurotensin decreases with fasting in the ventromedian nucleus of obese Zucker rats. , 1995, Metabolism: clinical and experimental.

[55]  A. Sclafani Animal models of obesity: classification and characterization. , 1984, International journal of obesity.

[56]  K. Nakao,et al.  Endogenous opioids and related peptides: from molecular biology to clinical medicine. The Sir Henry Dale lecture for 1985. , 1985, The Journal of endocrinology.

[57]  A. Pol,et al.  A fine-grained anatomical analysis of the role of the rat suprachiasmatic nucleus in circadian rhythms of feeding and drinking , 1979, Brain Research.

[58]  P. Sawchenko,et al.  Organization of galanin‐immunoreactive inputs to the paraventricular nucleus with special reference to their relationship to catecholaminergic afferents , 1987, The Journal of comparative neurology.

[59]  J. Morley,et al.  Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects , 1988, Brain Research.

[60]  R. Steiner,et al.  Short-term starvation decreases POMC mRNA but does not alter GnRH mRNA in the brain of adult male rats. , 1992, Neuroendocrinology.

[61]  J. Friedman,et al.  Abnormal splicing of the leptin receptor in diabetic mice , 1996, Nature.

[62]  M. G. Dube,et al.  Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats. , 1992, Endocrinology.

[63]  A. Sclafani Neural pathways involved in the ventromedial hypothalamic lesion syndrome in the rat. , 1971, Journal of comparative and physiological psychology.

[64]  S. Whitebread,et al.  Inhibition of Food Intake by Neuropeptide Y Y5 Receptor Antisense Oligodeoxynucleotides , 1997, Diabetes.

[65]  B. Beck,et al.  Enhanced feeding response to neuropeptide Y in hypothalamic neuropeptide Y-depleted rats. , 1996, European journal of pharmacology.

[66]  M. G. Dube,et al.  Evidence of a physiological role for neuropeptide Y in ventromedial hypothalamic lesion-induced hyperphagia , 1995, Brain Research.

[67]  T. Pedrazzini,et al.  Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor , 1998, Nature Medicine.

[68]  Shoji Nakamura,et al.  Effect of bilateral lesions of the suprachiasmatic nuclei on the circadian rhythm of food-intake , 1978, Brain Research.

[69]  A. Pol Glutamate and aspartate immunoreactivity in hypothalamic presynaptic axons. , 1991 .

[70]  M. Suda,et al.  Effect of starvation on the circadian adrenocortical rhythm in rats. , 1980, Endocrinology.

[71]  N. Lambert,et al.  The mechanism of biphasic GABA responses , 1995, Science.

[72]  H. Bokil,et al.  Effect of intracerebroventricular and intravenous insulin on Fos-immunoreactivity in the rat brain , 1997, Neuroscience Letters.

[73]  T. Horvath,et al.  The Interactive Language of the Hypothalamus for the Gonadotropin Releasing Hormone (GNRH) System , 1997, Journal of neuroendocrinology.

[74]  R. Steiner,et al.  Diurnal Rhythm in Proopiomelanocortin mRNA in the Arcuate Nucleus of the Male Rat , 1994, Journal of neuroendocrinology.

[75]  J. Morley Neuropeptide regulation of appetite and weight. , 1987, Endocrine reviews.

[76]  S. Kalra,et al.  Evidence that Hypothalamic Neuropeptide Y Gene Expression Increases Before the Onset of the Preovulatory LH Surge * , 1995, Journal of neuroendocrinology.

[77]  P. Lambert,et al.  The effect of central blockade of kappa-opioid receptors on neuropeptide Y-induced feeding in the rat , 1993, Brain Research.

[78]  M. E. Lewis,et al.  Anatomy of the CNS opioid systems , 1985, Trends in Neurosciences.

[79]  R. Palmiter,et al.  Attenuation of the Obesity Syndrome of ob/ob Mice by the Loss of Neuropeptide Y , 1996, Science.

[80]  S. Woods,et al.  Leptin Increases Hypothalamic Pro-opiomelanocortin mRNA Expression in the Rostral Arcuate Nucleus , 1997, Diabetes.

[81]  M. G. Dube,et al.  Structure-function analysis of stimulation of food intake by neuropeptide Y: Effects of receptor agonists , 1991, Physiology & Behavior.

[82]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[83]  M. G. Dube,et al.  Disruption in neuropeptide Y and leptin signaling in obese ventromedial hypothalamic-lesioned rats 1 This study was presented in part at the 22nd Annual Meeting of the Society for Neuroscience, Anaheim, CA, in October 1992. 1 , 1999, Brain Research.

[84]  S. Woods,et al.  Glucagon-like peptide-1 and satiety , 1997, Nature.

[85]  M. Schwartz,et al.  Estradiol inhibits the increase of hypothalamic neuropeptide Y messenger ribonucleic acid expression induced by weight loss in ovariectomized rats. , 1995, Endocrinology.

[86]  P. J. Larsen,et al.  Regional Distribution of Putative NPY Y1 Receptors and Neurons Expressing Y1 mRNA in Forebrain Areas of the Rat Central Nervous System , 1993, The European journal of neuroscience.

[87]  M. Jones,et al.  Factors involved in the regulation of adrenocorticotropic hormone/beta-lipotropic hormone. , 1988, Physiological reviews.

[88]  J. Polak,et al.  Increased Hypothalamic Neuropeptide Y Concentrations in Diabetic Rat , 1988, Diabetes.

[89]  J. Kelly,et al.  GABA and hypothalamic feeding systems. I. Topographic analysis of the effects of microinjections of muscimol , 1979, Physiology & Behavior.

[90]  J. Flier,et al.  Identification of SOCS-3 as a potential mediator of central leptin resistance. , 1998, Molecular cell.

[91]  J. Wikberg,et al.  Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): evaluation in vitro and in vivo. , 1998, Endocrinology.

[92]  R. Carraway,et al.  The amino acid sequence of a hypothalamic peptide, neurotensin. , 1975, The Journal of biological chemistry.

[93]  S. Kalra,et al.  c-fos expression in the rat brain following central administration of neuropeptide Y and effects of food consumption , 1994, Brain Research.

[94]  B. Hoebel,et al.  Neurotensin: Effects of hypothalamic and intravenous injections on eating and drinking in rats , 1983, Peptides.

[95]  A. N. van den Pol,et al.  Glutamate, the dominant excitatory transmitter in neuroendocrine regulation. , 1990, Science.

[96]  M. G. Dube,et al.  Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[97]  R. Quirion,et al.  Expression and Characterization of the Neuropeptide Y Y5 Receptor Subtype in the Rat Brain , 1998, The Journal of Neuroscience.

[98]  S. Bloom,et al.  Leptin interacts with glucagon‐like peptide‐1 neurons to reduce food intake and body weight in rodents , 1997, FEBS letters.

[99]  S. Leibowitz,et al.  Impact of a galanin antagonist on exogenous galanin and natural patterns of fat ingestion , 1992, Brain Research.

[100]  L. Renaud,et al.  Electrophysiology of suprachiasmatic nucleus projections to hypothalamic paraventricular nucleus neurons. , 1996, Progress in brain research.

[101]  K. Fuxe,et al.  Regional differences in glucocorticoid receptor immunoreactivity among neuropeptide Y immunoreactive neurons of the rat brain. , 1989, Acta physiologica Scandinavica.

[102]  M. G. Dube,et al.  Evidence that neuropeptide Y is a physiological signal for normal food intake , 1994, Brain Research.

[103]  John T. Clark,et al.  Alpha2-adrenoceptor blockade attenuates feeding behavior induced by neuropeptide Y and epinephrine , 1988, Physiology & Behavior.

[104]  R. Considine,et al.  Leptin: The Tale of an Obesity Gene , 1996, Diabetes.

[105]  Y. Watanabe,et al.  Hypothalamic galanin-like immunoreactivity and its gene expression in relation to circulating corticosterone. , 1994, Brain research. Molecular brain research.

[106]  B. Chronwall Anatomy and physiology of the neuroendocrine arcuate nucleus , 1985, Peptides.

[107]  J. Powell,et al.  An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat , 1985, Brain Research.

[108]  S. Kalra,et al.  Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes , 1997, Brain Research.

[109]  T. Horvath Neuropeptide-Y innervation of beta-endorphin-containing cells in the rat mediobasal hypothalamus: a light and electron microscopic double immunostaining analysis [published erratum appears in Endocrinology 1996 Feb;137(2):532] , 1992 .

[110]  L W Swanson,et al.  Organization of projections from the dorsomedial nucleus of the hypothalamus: A PHA‐L study in the rat , 1996, The Journal of comparative neurology.

[111]  R. Devos,et al.  Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. , 1995, Science.

[112]  C. Léránth,et al.  Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations , 1997, Brain Research.

[113]  S. Kalra,et al.  Localization of neuropeptide-Y immunoreactivity in estradiol-concentrating cells in the hypothalamus. , 1990, Endocrinology.

[114]  M. Morris,et al.  Modulation of neuropeptide Y overflow by leptin in the rat hypothalamus, cerebral cortex and medulla , 1998, Neuroreport.

[115]  M. G. Dube,et al.  Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action 1 This study was presented in part at the 28th Annual Meeting of the Society for Neuroscience, Los Angeles, CA, in November 1998. 1 , 1999, Brain Research.

[116]  J. Sturis,et al.  Ultradian oscillations of leptin secretion in humans. , 1996, Biochemical and biophysical research communications.

[117]  T. Castonguay,et al.  Meal patterns of rats with dorsomedial hypothalamic nuclei lesions or sham operations , 1986, Physiology & Behavior.

[118]  F. Lönnqvist,et al.  Overexpression of the obese (ob) gene in adipose tissue of human obese subjects , 1995, Nature Medicine.

[119]  P. J. Larsen,et al.  Chronic Administration of Glucocorticoids Directly Upregulates Prepro‐Neuropeptide Y and Y1‐Receptor mRNA Levels in the Arcuate Nucleus of the Rat , 1994, Journal of neuroendocrinology.

[120]  K. McCowen,et al.  Leptin signaling in the hypothalamus of normal rats in vivo. , 1998, Endocrinology.

[121]  B. Roland,et al.  Local origins of some GABAergic projections to the paraventricular and supraoptic nuclei of the hypothalamus in the rat , 1993, The Journal of comparative neurology.

[122]  S. Kalra,et al.  Nutritional Infertility: The Role of the Interconnected Hypothalamic Neuropeptide Y–Galanin–Opioid Network , 1996, Frontiers in Neuroendocrinology.

[123]  J. Friedman,et al.  Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[124]  G. Mogenson,et al.  Reversible hyperphagia and obesity following intracerebral microinjections of colchicine into the ventromedial hypothalamus of the rat , 1978, Brain Research.

[125]  R. Considine,et al.  Response of leptin to short-term and prolonged overfeeding in humans. , 1996, The Journal of clinical endocrinology and metabolism.

[126]  W. Pilcher,et al.  Immunocytochemical localization of ACTH perikarya in nucleus tractus solitarius: evidence for a second opiocortin neuronal system , 1983, Neuroscience Letters.

[127]  P. J. Larsen,et al.  Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. , 1996, The American journal of physiology.

[128]  S. Bloom,et al.  Increased Neuropeptide Y Concentrations in Specific Hypothalamic Regions of Streptozocin-Induced Diabetic Rats , 1989, Diabetes.

[129]  O. Bosler,et al.  Serotonin innervation of neuropeptide Y-containing neurons in the rat arcuate nucleus , 1988, Neuroscience Letters.

[130]  C. Léránth,et al.  Morphological Evidence for a Galanin‐Opiate Interaction in the Rat Mediobasal Hypothalamus , 1995, Journal of neuroendocrinology.

[131]  M. Smith,et al.  Neuropeptide Y (NPY) neurons in the arcuate nucleus (ARH) and dorsomedial nucleus (DMH), areas activated during lactation, project to the paraventricular nucleus of the hypothalamus (PVH) , 1998, Regulatory Peptides.

[132]  H. Vaudry,et al.  Regulation of α‐Melanocyte‐Stimulating Hormone Release from Hypothalamic Neurons a , 1993 .

[133]  P. J. Larsen,et al.  Hypothalamic CART is a new anorectic peptide regulated by leptin , 1998, Nature.

[134]  L W Swanson,et al.  Efferent projections of the suprachiasmatic nucleus: I. Studies using anterograde transport of Phaseolus vulgaris leucoagglutinin in the rat , 1987, The Journal of comparative neurology.

[135]  P. Morgan,et al.  Coexpression of Leptin Receptor and Preproneuropeptide Y mRNA in Arcuate Nucleus of Mouse Hypothalamus , 1996, Journal of neuroendocrinology.

[136]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[137]  M. G. Dube,et al.  Effect of D-fenfluramine on neuropeptide Y concentration and release in the paraventricular nucleus of food-deprived rats , 1992, Brain Research Bulletin.

[138]  C. Léránth,et al.  Naloxone reduces the feeding evoked by intracerebroventricular galanin injection , 1994, Physiology & Behavior.

[139]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[140]  K. Tatemoto Neuropeptide Y: complete amino acid sequence of the brain peptide. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[141]  C. Walker,et al.  Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats. , 1989, Endocrinology.

[142]  S. Kalra,et al.  Is neuropeptide Y a naturally occurring appetite transducer , 1996 .

[143]  S. Leibowitz,et al.  Suppression of neuropeptide Y-elicited eating by adrenalectomy or hypophysectomy: reversal with corticosterone , 1989, Brain Research.

[144]  Y Watanabe,et al.  Galanin-containing neurons in the paraventricular nucleus: a neurochemical marker for fat ingestion and body weight gain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[145]  N. Hoggard,et al.  Localization of leptin receptor mRNA and the long form splice variant (Ob‐Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization , 1996, FEBS letters.

[146]  T. Hökfelt,et al.  Peptide‐ and transmitter‐containing neurons in the mediobasal hypothalamus and their relation to GABAergic systems: Possible roles in control of prolactin and growth hormone secretion , 1988, Synapse.

[147]  P. Muzzin,et al.  Correction of obesity and diabetes in genetically obese mice by leptin gene therapy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[148]  P. Widdowson Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 ‘feeding’ receptor , 1997, Brain Research.

[149]  S. Chua,et al.  Critical effects of aging and nutritional state on hypothalamic neuropeptide Y and galanin gene expression in lean and genetically obese Zucker rats. , 1993, Brain research. Molecular brain research.

[150]  C. Léránth,et al.  Neuropeptide-Y innervation of beta-endorphin-containing cells in the rat mediobasal hypothalamus: a light and electron microscopic double immunostaining analysis. , 1992, Endocrinology.

[151]  C. Donaldson,et al.  Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor. , 1993, Endocrinology.

[152]  G. Bray,et al.  Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity , 1994, Peptides.

[153]  S. Leibowitz Hypothalamic Neuropepitide Y, Galanin, and Amines Concepts of Coexistence in Relation to Feeding Behavior a , 1989, Annals of the New York Academy of Sciences.

[154]  P. Lambert,et al.  Increases in neuropeptide Y content and gene expression in the hypothalamus of rats treated with dexamethasone are prevented by insulin. , 1993, Neuroendocrinology.

[155]  G. Pasternak,et al.  Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats , 1995, Brain Research.

[156]  G. Barsh,et al.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.

[157]  L W Swanson,et al.  Efferent projections of the suprachiasmatic nucleus: II. Studies using retrograde transport of fluorescent dyes and simultaneous peptide immunohistochemistry in the rat , 1987, The Journal of comparative neurology.

[158]  S. Leibowitz,et al.  Differential effects of galanin and neuropeptide Y on extracellular norepinephrine levels in the paraventricular hypothalamic nucleus of the rat: a microdialysis study. , 1992, Life sciences.

[159]  I. Merchenthaler,et al.  Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. , 1996, Endocrinology.

[160]  J. Ohannesian,et al.  Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. , 1996, The Journal of clinical investigation.

[161]  S. Dryden,et al.  The serotonergic agent fluoxetine reduces neuropeptide y levels and neuropeptide y secretion in the hypothalamus of lean and obese rats , 1996, Neuroscience.

[162]  M. G. Dube,et al.  Bilateral neural transections at the level of mesencephalon increase food intake and reduce latency to onset of feeding in response to neuropeptide Y , 1988, Peptides.

[163]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[164]  R. Mains,et al.  Structure and biosynthesis of pro-adrenocorticotropin/endorphin and related peptides. , 1980, Endocrine reviews.

[165]  S. Leibowitz,et al.  Galanin: stimulation of feeding induced by medial hypothalamic injection of this novel peptide. , 1986, European journal of pharmacology.

[166]  T. O'donohue,et al.  alpha-Melanocyte stimulating hormone: immunohistochemical identification and mapping in neurons of rat brain. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[167]  C. Wahlestedt,et al.  Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat , 1987, Brain Research.

[168]  S. Leibowitz,et al.  Diurnal rhythm of galanin-like immunoreactivity in the paraventricular and suprachiasmatic nuclei and other hypothalamic areas , 1994, Peptides.

[169]  John T. Clark,et al.  Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met17]NPY), NPY analog ([norLeu4]NPY) and peptide YY , 1987, Regulatory Peptides.

[170]  Michael W. Schwartz,et al.  Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons , 1998, Nature Neuroscience.

[171]  G. Sanacora,et al.  Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. , 1990, Endocrinology.

[172]  R. Seeley,et al.  Melanocortin receptors in leptin effects , 1997, Nature.

[173]  C. Léránth,et al.  GABAergic and catecholaminergic innervation of mediobasal hypothalamic β-endorphin cells projecting to the medial preoptic area , 1992, Neuroscience.

[174]  R. Steiner,et al.  Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat. , 1996, Endocrinology.

[175]  N. Miller,et al.  OBESITY FROM EATING ELICITED BY DAILY STIMULATION OF HYPOTHALAMUS. , 1965, The American journal of physiology.

[176]  E. Ravussin,et al.  Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects , 1995, Nature Medicine.

[177]  H. Akil,et al.  Diurnal corticotropin-releasing hormone mRNA variation in the hypothalamus exhibits a rhythm distinct from that of plasma corticosterone. , 1992, Neuroendocrinology.

[178]  S. Kalra,et al.  Neuropeptide Y injection into the fourth cerebroventricle stimulates c-Fos expression in the paraventricular nucleus and other nuclei in the forebrain: effect of food consumption , 1995, Brain Research.

[179]  W. Farmerie,et al.  Printed in U.S.A. Copyright © 1998 by The Endocrine Society Anorectic Effects of the Cytokine, Ciliary Neurotropic Factor, Are Mediated by Hypothalamic Neuropeptide Y: Comparison with Leptin* , 2022 .

[180]  G. Alheid,et al.  GABA stimulation and blockade in the hypothalamus and midbrain: Effects on feeding and locomotor activity , 1977, Pharmacology Biochemistry and Behavior.

[181]  C. Plata-salamán Immunoregulators in the nervous system , 1991, Neuroscience & Biobehavioral Reviews.

[182]  S. Bloom,et al.  Characterization of glucagon-like peptide-1-(7–36)amide in the hypothalamus , 1989, Brain Research.

[183]  S. Woods,et al.  Central infusions of leptin and GLP-1-(7-36) amide differentially stimulate c-FLI in the rat brain. , 1996, The American journal of physiology.

[184]  K. Arai,et al.  Roles of the JAK-STAT system in signal transduction via cytokine receptors. , 1996, Current opinion in genetics & development.

[185]  S. Kalra,et al.  Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. , 1990, Endocrinology.

[186]  J. Auwerx,et al.  Transient increase in obese gene expression after food intake or insulin administration , 1995, Nature.

[187]  F E Bloom,et al.  Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[188]  M. G. Dube,et al.  Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis. , 1995, Endocrinology.

[189]  A. Fournier,et al.  Regulation of proopiomelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus , 1995, Brain Research.

[190]  P. J. Larsen,et al.  A high concentration of NPY (Y1)-receptor mRNA-expressing cells in the rat arcuate nucleus , 1992, Neuroscience Letters.

[191]  M. Miller,et al.  Distribution of neurotensin/neuromedin N mRNA in rat forebrain: unexpected abundance in hippocampus and subiculum. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[192]  C. Newgard,et al.  Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[193]  S. Watson,et al.  Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. , 1993, The Journal of biological chemistry.

[194]  S. Kalra,et al.  Evidence that NPY-containing neurons in the brainstem project into selected hypothalamic nuclei: implication in feeding behavior , 1988, Brain Research.

[195]  M. G. Dube,et al.  Anorectic effects of estrogen may be mediated by decreased neuropeptide-Y release in the hypothalamic paraventricular nucleus. , 1994, Endocrinology.

[196]  L. Tartaglia,et al.  The Leptin Receptor* , 1997, The Journal of Biological Chemistry.

[197]  W. Vale,et al.  Secretion of melanin-concentrating hormone and neuropeptide-EI from cultured rat hypothalamic cells. , 1992, Endocrinology.

[198]  S. Gammeltoft,et al.  A role for melanin-concentrating hormone in the central regulation of feeding behaviour , 1996, Nature.

[199]  C. Mantzoros,et al.  Role of leptin in the neuroendocrine response to fasting , 1996, Nature.

[200]  D. Macneil,et al.  NPY-induced feeding involves the action of a Y1-like receptor in rodents , 1998, Regulatory Peptides.

[201]  M. Mortrud,et al.  Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. , 1994, Molecular endocrinology.

[202]  S. Leibowitz,et al.  Stimulation of feeding by galanin: Anatomical localization and behavioral specificity of this peptide's effects in the brain , 1990, Peptides.

[203]  P. Petrusz,et al.  Immunocytochemical Localization of β-Endorphin-Containing Neurons in the Rat Brain , 1981 .

[204]  Y. Konda,et al.  Molecular cloning, expression, and characterization of a fifth melanocortin receptor. , 1994, Biochemical and biophysical research communications.

[205]  M. Smith,et al.  Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels , 1997, Nature.

[206]  Y. Smith,et al.  CART peptides in the central control of feeding and interactions with neuropeptide Y , 1998, Synapse.

[207]  S. Kalra,et al.  Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. 1985. , 1985, Obesity research.

[208]  Shelagh Wilson,et al.  Interactions Between Leptin and Hypothalamic Neuropeptide Y Neurons in the Control of Food Intake and Energy Homeostasis in the Rat , 1997, Diabetes.

[209]  J. Leban,et al.  High-affinity neuropeptide Y receptor antagonists. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[210]  S. Dryden,et al.  Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats , 1995, Brain Research.

[211]  P. Lambert,et al.  Naloxone-induced anorexia increases neuropeptide Y concentrations in the dorsomedial hypothalamus: Evidence for neuropeptide Y-opioid interactions in the control of food intake , 1994, Peptides.

[212]  B. Morris,et al.  Long-term blockade of μ-opioid receptors suggests a role in control of ingestive behaviour, body weight and core temperature in the rat , 1988, Brain Research.

[213]  J. Friedman,et al.  Physiological response to long-term peripheral and central leptin infusion in lean and obese mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[214]  K. Polonsky,et al.  Leptin, the obese gene product, rapidly modulates synaptic transmission in the hypothalamus. , 1996, Molecular pharmacology.

[215]  J. Shutter,et al.  Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. , 1997, Genes & development.

[216]  S. Lin,et al.  Localization of leptin receptor mRNA expression in mouse brain. , 1996, Neuroreport.

[217]  J. Morley,et al.  Opioid modulation of appetite , 1983, Neuroscience & Biobehavioral Reviews.

[218]  W. Farmerie,et al.  Evidence that Dark-Phase Hyperphagia Induced by Neurotoxin 6-Hydroxydopamine May Be Due to Decreased Leptin and Increased Neuropeptide Y Signaling , 1998, Physiology & Behavior.

[219]  G. Kinney,et al.  Regulation of Neurotransmission in the Arcuate Nucleus of the Rat by Different Neuropeptide Y Receptors , 1997, The Journal of Neuroscience.

[220]  Hoebel Bg Neurotransmitters in the control of feeding and its rewards: monoamines, opiates, and brain-gut peptides. , 1984 .

[221]  A. Hulting,et al.  Expression of leptin receptor mRNA in the hypothalamic arcuate nucleus - relationship with NPY neurones , 1996, Neuroreport.

[222]  J. Funder,et al.  Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. , 1988, Endocrine reviews.

[223]  T. Horvath,et al.  Interactions between Neuropeptide Y and γ -Aminobutyric Acid in Stimulation of Feeding: A Morphological and Pharmacological Analysis. , 1999, Endocrinology.

[224]  M. Berelowitz,et al.  Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats. , 1990, Endocrinology.

[225]  S. Hisano,et al.  Localization of glucocorticoid receptor in neuropeptide Y-containing neurons in the arcuate nucleus of the rat hypothalamus , 1988, Neuroscience Letters.

[226]  G. Koob,et al.  Appetite-Suppressing Effects of Urocortin, a CRF-Related Neuropeptide , 1996, Science.

[227]  Gareth H. Williams,et al.  Acute fenfluramine administration reduces neuropeptide Y concentrations in specific hypothalamic regions of the rat: Possible implications for the anorectic effect of fenfluramine , 1991, Peptides.

[228]  S. Kalra,et al.  Neural substrates for leptin and neuropeptide Y (NPY) interaction: hypothalamic sites associated with inhibition of NPY-induced food intake , 1998, Physiology & Behavior.

[229]  J. Vaughan,et al.  The melanin‐concentrating hormone system of the rat brain: An immuno‐ and hybridization histochemical characterization , 1992, The Journal of comparative neurology.

[230]  R. Carraway,et al.  The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. , 1973, The Journal of biological chemistry.

[231]  K. Koller,et al.  Pharmacological characterization and selectivity of the NPY antagonist GR231118 (1229U91) for different NPY receptors , 1997, Regulatory Peptides.

[232]  R. Buijs The anatomical basis for the expression of circadian rhythms: the efferent projections of the suprachiasmatic nucleus. , 1996, Progress in brain research.

[233]  A. N. van den Pol,et al.  Synaptic Interaction between Hypocretin (Orexin) and Neuropeptide Y Cells in the Rodent and Primate Hypothalamus: A Novel Circuit Implicated in Metabolic and Endocrine Regulations , 1999, The Journal of Neuroscience.

[234]  G. Bray Hypothalamic and genetic obesity: an appraisal of the autonomic hypothesis and the endocrine hypothesis. , 1984, International journal of obesity.

[235]  K. Feingold,et al.  Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. , 1992, The New England journal of medicine.

[236]  S. Leibowitz,et al.  Peptide-amine interactions in the hypothalamic paraventricular nucleus: analysis of galanin and neuropeptide Y in relation to feeding , 1990, Brain Research.

[237]  R. Palmiter,et al.  Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y , 1996, Nature.

[238]  Yinghe Hu,et al.  Identification of a Novel Hypothalamic Neuropeptide Y Receptor Associated with Feeding Behavior* , 1996, The Journal of Biological Chemistry.

[239]  B. Stanley,et al.  NEUROTENSIN INJECTED INTO THE PARAVENTRICULAR HYPOTHALAMUS SUPPRESSES FEEDING IN RATS , 1982 .

[240]  L. Moldawer,et al.  Cachectin: its impact on metabolism and nutritional status. , 1988, Annual review of nutrition.

[241]  A. Viale,et al.  Impaired processing of brain proneurotensin and promelanin-concentrating hormone in obese fat/fat mice. , 1996, Endocrinology.

[242]  M. G. Dube,et al.  Continuous intraventricular infusion of neuropeptide Y evokes episodic food intake in satiated female rats: Effects of adrenalectomy and cholecystokinin , 1988, Peptides.

[243]  P. Petrusz,et al.  The immunocytochemical localization of enkephalin in the central nervous system of the rat , 1981, The Journal of comparative neurology.

[244]  P. Couceyro,et al.  PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[245]  B. Griffond,et al.  Activation of the rat melanin-concentrating hormone neurons by ventromedial hypothalamic lesions , 1994, Neuropeptides.

[246]  L W Swanson,et al.  Hypothalamic integration: organization of the paraventricular and supraoptic nuclei. , 1983, Annual review of neuroscience.

[247]  T. Miyoshi,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Melanin-Concentrating Hormone Acutely Stimulates Feeding, But Chronic Administration Has No Effect on , 2022 .

[248]  F. Antoni,et al.  Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. , 1986, Endocrine reviews.

[249]  C. Léránth,et al.  Morphological and pharmacological evidence for neuropeptide Y-galanin interaction in the rat hypothalamus. , 1996, Endocrinology.

[250]  S. Kanse,et al.  Identification and characterization of glucagon‐like peptide‐1 7–36 amide‐binding sites in the rat brain and lung , 1988, FEBS letters.

[251]  J. Vaughan,et al.  Characterization of melanin-concentrating hormone from rat hypothalamus. , 1989, Endocrinology.

[252]  J. Beauvillain,et al.  Semiquantitative distribution of galanin-receptor (GAL-R1) mRNA-containing cells in the male rat hypothalamus. , 1997, Neuroendocrinology.

[253]  Roy J Martin,et al.  Adrenalectomy decreases neuropeptide Y mRNA levels in the arcuate nucleus , 1990, Brain Research Bulletin.

[254]  R. Cone,et al.  Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti obesity syndrome. , 1997, Molecular endocrinology.

[255]  B. Lowell,et al.  Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity. , 1995, The Journal of clinical investigation.

[256]  L. Moldawer,et al.  Leptin and ciliary neurotropic factor (CNTF) inhibit fasting-induced suppression of luteinizing hormone release in rats: role of neuropeptide Y , 1998, Neuroscience Letters.

[257]  A. Stunkard Current views on obesity. , 1996, The American journal of medicine.

[258]  A. Sclafani,et al.  Paraventricular hypothalamic lesions and medial hypothalamic knife cuts produce similar hyperphagia syndromes. , 1983, Behavioral neuroscience.

[259]  W. Vale,et al.  Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin , 1981 .

[260]  S. Ritter,et al.  Aqueduct occlusion does not impair feeding induced by either third or fourth ventricle galanin injection. , 1997, Obesity research.

[261]  P. Prusis,et al.  Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist , 1999, British journal of pharmacology.

[262]  L. Campfield,et al.  Feeding inhibition by neuropeptide Y , 1996, Nature.

[263]  F. Rohner-Jeanrenaud A neuroendocrine reappraisal of the dual-centre hypothesis: its implications for obesity and insulin resistance. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[264]  C. Billington,et al.  Opioids Are They Regulators of Feeding? a , 1989, Annals of the New York Academy of Sciences.

[265]  J. Darnell,et al.  Leptin activation of Stat3 in the hypothalamus of wild–type and ob/ob mice but not db/db mice , 1996, Nature Genetics.

[266]  Crisp Ah The psychopathology of anorexia nervosa: getting the "heat" out of the system. , 1984 .

[267]  S. Kalra,et al.  Steroidal regulation of hypothalamic neuropeptide Y release and gene expression. , 1992, Endocrinology.

[268]  M. Pelleymounter,et al.  Effects of the obese gene product on body weight regulation in ob/ob mice. , 1995, Science.

[269]  J. Wikberg,et al.  Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats. , 1998, Biochemical and biophysical research communications.

[270]  R. Steiner,et al.  Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus. , 1997, Endocrinology.

[271]  G. Shulman,et al.  The Effect of Leptin Is Enhanced by Microinjection Into the Ventromedial Hypothalamus , 1997, Diabetes.

[272]  R. Seeley,et al.  Identification of targets of leptin action in rat hypothalamus. , 1996, The Journal of clinical investigation.

[273]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[274]  G. Bray,et al.  Neuroendocrine control of the development of obesity : understanding gained from studies of experimental animal models , 1990 .

[275]  D. Jezova,et al.  Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrier. , 1992, Endocrinology.

[276]  S. Leibowitz,et al.  Feeding and drinking elicited by central injection of neuropeptide Y: Evidence for a hypothalamic site(s) of action , 1985, Brain Research Bulletin.

[277]  Craig W. Berridge,et al.  Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? , 1990, Brain Research Reviews.

[278]  S. Nicolaidis,et al.  Melanin-concentrating hormone is a potent anorectic peptide regulated by food-deprivation and glucopenia in the rat , 1996, Neuroscience.

[279]  P. Lambert,et al.  A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivation. , 1993, Endocrinology.

[280]  J. Crawley,et al.  Galanin and the galanin antagonist M40 do not change fat intake in a fat-chow choice paradigm in rats. , 1995, The American journal of physiology.

[281]  R. Cone,et al.  Independent and additive effects of central POMC and leptin pathways on murine obesity. , 1997, Science.

[282]  M. Stock,et al.  Leptin activation in hypothalamus , 1996, Nature.

[283]  P. Luiten,et al.  The projections of the dorsomedial hypothalamic nucleus in the rat , 1986, Brain Research Bulletin.

[284]  M. Deitel,et al.  Increased obese mRNA expression in omental fat cells from massively obese humans , 1995, Nature Medicine.

[285]  A. N. van den Pol,et al.  GABA: A dominant neurotransmitter in the hypothalamus , 1990, The Journal of comparative neurology.

[286]  L. Moldawer,et al.  Increased appetite augments hypothalamic NPY Y1 receptor gene expression: effects of anorexigenic ciliary neurotropic factor 1 Presented in part at the 27th Annual Meeting of the Society for Neuroscience, New Orleans, LA, vol. 23, p. 1343 #528.2. 1 , 1998, Regulatory Peptides.

[287]  D. Jacobowitz,et al.  Immunohistochemical localization of a melanin concentrating hormone-like peptide in the rat brain , 1985, Brain Research Bulletin.

[288]  T. Hökfelt,et al.  Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. , 1997, Neuroendocrinology.

[289]  H. Akil,et al.  Diurnal CRH mRNA rhythm in the hypothalamus: decreased expression in the evening is not dependent on endogenous glucocorticoids. , 1993, Neuroendocrinology.

[290]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[291]  Richard P. Woychik,et al.  Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor , 1994, Nature.

[292]  M. Hawkins Central nervous system neurotensin and feeding , 1986, Physiology & Behavior.

[293]  A. Sahu Evidence suggesting that galanin (GAL), melanin-concentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y (NPY) are targets of leptin signaling in the hypothalamus. , 1998, Endocrinology.

[294]  G. Barsh,et al.  Obesity, diabetes, and neoplasia in yellow Avy/‐ mice: ectopic expression of the agouti gene , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[295]  G. R. Leon,et al.  Obesity: psychological causes, correlations, and speculations. , 1977, Psychological bulletin.

[296]  J. Kelly,et al.  GABA and hypothalamic feeding systems , 1979, Brain Research Bulletin.

[297]  L. Bellinger,et al.  The dorsomedial hypothalamic nucleus revisited: 1986 update , 1987, Brain Research Reviews.

[298]  P. J. Larsen,et al.  Direct projection from the suprachiasmatic nucleus to hypophysiotrophic corticotropin-releasing factor immunoreactive cells in the paraventricular nucleus of the hypothalamus demonstrated by means ofPhaseolus vulgaris-leucoagglutinin tract tracing , 1995, Brain Research.

[299]  Y. Taché,et al.  CRF in the paraventricular nucleus of the hypothalamus induces dose-related behavioral profile in rats , 1992, Brain Research.

[300]  Victor J. Hruby,et al.  Role of melanocortinergic neurons in feeding and the agouti obesity syndrome , 1997, Nature.

[301]  S. Woods,et al.  Insulin in the brain: a hormonal regulator of energy balance. , 1992, Endocrine reviews.

[302]  S. Leibowitz,et al.  The perifornical area: the major focus of (a) patchily distributed hypothalamic neuropeptide Y-sensitive feeding system(s) , 1993, Brain Research.

[303]  M. Mortrud,et al.  The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.

[304]  M. G. Dube,et al.  Hypothalamic Galanin Is Upregulated during Hyperphagiaa , 1998 .

[305]  S. Leibowitz Paraventricular nucleus: A primary site mediating adrenergic stimulation of feeding and drinking , 1978, Pharmacology Biochemistry and Behavior.

[306]  T. Hökfelt,et al.  Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus , 1988, Neuroscience.

[307]  R. Skoda,et al.  Defective STAT signaling by the leptin receptor in diabetic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[308]  R. Steiner,et al.  Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. , 1997, Endocrinology.

[309]  T. Lovenberg,et al.  Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[310]  J. Wikberg,et al.  Evidence that orexigenic effects of melanocortin 4 receptor antagonist HS014 are mediated by neuropeptide Y. , 1998, Biochemical and biophysical research communications.

[311]  P. Prusis,et al.  Discovery of novel melanocortin4 receptor selective MSH analogues , 1998, British journal of pharmacology.

[312]  L. Tartaglia,et al.  Evidence That the Diabetes Gene Encodes the Leptin Receptor: Identification of a Mutation in the Leptin Receptor Gene in db/db Mice , 1996, Cell.

[313]  B. Göke,et al.  Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. , 1995, Endocrine reviews.

[314]  P S Kalra,et al.  Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. , 1984, Endocrinology.

[315]  G. Koob,et al.  Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. , 1982, Life sciences.

[316]  M. Dallman,et al.  Feast and Famine: Critical Role of Glucocorticoids with Insulin in Daily Energy Flow , 1993, Frontiers in Neuroendocrinology.

[317]  S. Whitebread,et al.  A receptor subtype involved in neuropeptide-Y-induced food intake , 1996, Nature.

[318]  C. Saper,et al.  Leptin activates neurons in ventrobasal hypothalamus and brainstem. , 1997, Endocrinology.

[319]  G. Fisone,et al.  Galanin and galanin antagonists: molecular and biochemical perspectives. , 1992, Trends in pharmacological sciences.

[320]  R. Quirion,et al.  Neuropeptide y receptor types in the mammalian brain: Species differences and status in the human central nervous system , 1997 .

[321]  S. Chua,et al.  Food deprivation and hypothalamic neuropeptide gene expression: effects of strain background and the diabetes mutation. , 1991, Brain research. Molecular brain research.

[322]  W. Farmerie,et al.  Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: effects of food restriction. , 1999, Endocrinology.

[323]  C. Plata-salamán,et al.  Hyperphagia and obesity in rats with bilateral ibotenic acid-induced lesions of the ventromedial hypothalamic nucleus , 1987, Brain Research.

[324]  T. Murakami,et al.  Cloning of rat obese cDNA and its expression in obese rats. , 1995, Biochemical and biophysical research communications.

[325]  D. Macneil,et al.  Distribution of orexin receptor mRNA in the rat brain , 1998, FEBS letters.

[326]  C. Bouchard,et al.  Genetics of human obesity: research directions , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[327]  A. Steffens,et al.  University of Groningen The Hypothalamus, Intrinsic Connections and Outflow Pathways to the Endocrine System in Relation to the Control of Feeding and Metabolism Luiten, , 2002 .

[328]  J. Morley,et al.  Corticotrophin releasing factor, grooming and ingestive behavior. , 1982, Life sciences.

[329]  B. Thorens,et al.  Expression of the Glucagon‐Like Peptide‐1 Receptor Gene in Rat Brain , 1996, Journal of neurochemistry.

[330]  H. Weingarten,et al.  Comparison of the metabolic and behavioral disturbances following paraventricular- and ventromedial-hypothalamic lesions , 1985, Brain Research Bulletin.

[331]  M. Markman,et al.  Projections of the suprachiasmatic nucleus to stress‐related areas in the rat hypothalamus: A light and electron microscopic study , 1993, The Journal of comparative neurology.

[332]  C. Donaldson,et al.  Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[333]  R. Skoda,et al.  Leptin Receptor Immunoreactivity in Chemically Defined Target Neurons of the Hypothalamus , 1998, The Journal of Neuroscience.

[334]  T. Hökfelt,et al.  Occurrence of neurotensinlike immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons , 1984, The Journal of comparative neurology.

[335]  Potent neuropeptide Y Y1 receptor antagonist, 1229U91: blockade of neuropeptide Y-induced and physiological food intake. , 1996, Endocrinology.

[336]  J. Crawley,et al.  Galanin Antagonists Block Galanin‐induced Feeding in the Hypothalamus and Amygdala of the Rat , 1993, The European journal of neuroscience.

[337]  W. Farmerie,et al.  Neuropeptide Y (NDY) Y1 Receptoe mRNA is Upregulated in Association with Transient Hyperphagia and Body Weight Gain: Evidence for a Hypothalamic Site for Concurrent Development of Leptin Resistance , 1998, Journal of neuroendocrinology.

[338]  Jeffrey H. D. White,et al.  Glucocorticoids are Required for Food Deprivation‐Induced Increases in Hypothalamic Neuropeptide Y Expression , 1992, Journal of neuroendocrinology.

[339]  P. Sokoloff,et al.  Molecular cloning and characterization of the rat fifth melanocortin receptor. , 1994, Biochemical and biophysical research communications.

[340]  D. Smith,et al.  A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.

[341]  B. Jeanrenaud,et al.  Effect of Sustained Physiological Hyperinsulinaemia on Hypothalamic Neuropeptide Y and NPY mRNA Levels in the Rat , 1995, Journal of neuroendocrinology.

[342]  S. Kalra,et al.  Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus , 1988, Peptides.

[343]  S. Woods,et al.  Specificity of Leptin Action on Elevated Blood Glucose Levels and Hypothalamic Neuropeptide Y Gene Expression in ob/ob Mice , 1996, Diabetes.

[344]  K. Fuxe,et al.  NPY Y1 receptor like immunoreactivity exists in a subpopulation of β-endorphin immunoreactive nerve cells in the arcuate nucleus: a double immunolabelling analysis in the rat , 1997, Neuroscience Letters.

[345]  S. Leibowitz,et al.  Hypothalamic Neuropeptide Y and Its Gene Expression: Relation to Light/Dark Cycle and Circulating Corticosterone , 1994, Molecular and Cellular Neuroscience.

[346]  S. Armstrong A chronometric approach to the study of feeding behavior , 1980, Neuroscience & Biobehavioral Reviews.

[347]  S. Whitebread,et al.  The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes , 1998, Regulatory Peptides.

[348]  S. Kalra,et al.  Hypothalamic neuropeptide-Y gene expression increases before the onset of the ovarian steroid-induced luteinizing hormone surge. , 1994, Endocrinology.

[349]  C. Saper,et al.  Neuropeptide‐immunoreactive neurons projecting to the paraventricular hypothalamic nucleus in the rat , 1994, The Journal of comparative neurology.

[350]  R. Cortese,et al.  Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[351]  Shelagh Wilson,et al.  Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor? , 1998, Regulatory Peptides.

[352]  S. Kalra,et al.  Hypothalamic neuropeptide Y gene expression in rats on scheduled feeding regimen. , 1992, Brain research. Molecular brain research.

[353]  K. Fukui,et al.  Light and electron microscopic immunocytochemistry of neurotensin-like immunoreactive neurons in the rat hypothalamus , 1984, Brain Research.

[354]  N. Ling,et al.  Immunohistochemical Localization of Novel CART Peptides in Rat Hypothalamus, Pituitary and Adrenal Gland , 1997, Journal of neuroendocrinology.

[355]  A. Burlet,et al.  Galanin in the hypothalamus of fed and fasted lean and obese Zucker rats , 1993, Brain Research.

[356]  T. Horvath Suprachiasmatic efferents avoid phenestrated capillaries but innervate neuroendocrine cells, including those producing dopamine. , 1997, Endocrinology.

[357]  J. Lauder,et al.  Distribution of glucagonlike peptide I (GLP‐I), glucagon, and glicentin in the rat brain: An immunocytochemical study , 1988, The Journal of comparative neurology.

[358]  L. V. D. van der Ploeg,et al.  Molecular cloning and characterization of a new receptor for galanin , 1997, FEBS letters.

[359]  M. Classen,et al.  Effect of galanin on food intake in rats: involvement of lateral and ventromedial hypothalamic sites. , 1993, The American journal of physiology.

[360]  C. Mantzoros,et al.  Human leptin levels are pulsatile and inversely related to pituitary–ardenal function , 1997, Nature Medicine.

[361]  B. Spiegelman,et al.  Adipogenesis and Obesity: Rounding Out the Big Picture , 1996, Cell.

[362]  J. Brobeck Mechanism of the development of obesity in animals with hypothalamic lesions. , 1946, Physiological reviews.

[363]  P. J. Larsen,et al.  Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem , 1997, Neuroscience.

[364]  M. Jhanwar-Uniyal,et al.  Diurnal rhythm of neuropeptide Y-like immunoreactivity in the suprachiasmatic, arcuate and paraventricular nuclei and other hypothalamic sites , 1990, Brain Research.

[365]  S. Kalra Appetite and Body Weight Regulation: Is It All in the Brain? , 1997, Neuron.

[366]  M. Smith Lactation alters neuropeptide-Y and proopiomelanocortin gene expression in the arcuate nucleus of the rat. , 1993, Endocrinology.

[367]  David Lovejoy,et al.  Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor , 1995, Nature.

[368]  S. Kalra,et al.  Neuropeptide Y stimulates β-endorphin release in the basal hypothalamus: role of gonadal steroids , 1995, Brain Research.

[369]  S. Kalra,et al.  Testosterone raises neuropeptide-Y concentration in selected hypothalamic sites and in vitro release from the medial basal hypothalamus of castrated male rats. , 1989, Endocrinology.

[370]  M. Herkenham,et al.  Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. , 1990, Neuroendocrinology.

[371]  M. G. Dube,et al.  Control of feeding and sexual behaviors by neuropeptide Y: Physiological implications , 1988, Synapse.